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Background: Hypertension is a major contributor to ill health in sub-Saharan Africa. Developing countries
need to increase access for screening. This study assesses the feasibility and acceptability of using private sec-
tor drug retail outlets to screen for hypertension in Mwanza region, Tanzania.
Methods: A pilot study took place in eight drug retail outlets from August 2013 to February 2014. Customers
≥18 years were invited for screening. Socio-demographic characteristics, hypertension knowledge, hyperten-
sion screening and treatment history were collected. Subjects with systolic blood pressure over 140 mmHg
were referred for follow up. Referral slips captured attendance. Mystery client visits and follow up phone calls
were conducted to assess service quality.
Results: A total of 971 customers were screened, one person refused; 109 (11.2%) had blood pressure over
140/90 mmHg and were referred for ongoing assessment; 85/109 (78.0%) were newly diagnosed. Customers
reported that the service was acceptable. Service providers were able to follow the protocol. Only 18/85 (21%)
newly diagnosed participants visited the referral clinic within two weeks.
Conclusions: Blood pressure screening was feasible and acceptable to customers of private drug retail outlets.
However many who were referred failed to attend at a referral centre and further research is needed in this area.
Keywords: Drug retail outlets, Hypertension, Pharmacies, Public–private partnerships, Screening, Tanzania
Introduction
Hypertension is a major contributor to ill health and premature
mortality globally.1–5 There is now strong evidence that hyperten-
sion is increasingly common in sub-Saharan Africa and
community-based surveys suggest that the prevalence of hyper-
tension is approaching that found in high-income countries.6
Studies conducted in rural Tanzania, Ghana and Cameroon have
found prevalence of hypertension among adults over the age of
40 years to vary between 20 and 30%.2,7–9 Despite this relatively
high prevalence, rates of detection, treatment and control of
hypertension in sub-Saharan Africa are generally low.9–18
In developed countries community-based screening by non-
physicians or non-clinicians has been shown to have added
advantages over routine screening for detecting hypertension in
individuals outside health care settings.10,11 Self-screening, as a
variant of community based screening for hypertension, is now
practiced as pharmacy-based screening.10,11 However there are
no studies of a similar approach in Africa.
This study was conducted in two districts of Mwanza region,
Tanzania to determine whether private drug retail outlets would
be a feasible and acceptable venue to screen individuals for
hypertension and subsequently direct them to proper care and
treatment.
Methods
Setting
The study was conducted in a rural (Magu: population of 299
759 [2012 Census]) and urban district (Nyamagana: population
of 363 452 [2012 Census]) in Mwanza region, in the Northwest
of Tanzania. The two districts were purposively selected to
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ensure representation of both urban and rural communities and
accessibility from the research centre.
Sampling and sample size
All private/government health facilities offering services for hyper-
tension in the study area and a list of all registered private drug
dispensing outlets (stratiﬁed by type) were provided by the district
medical ofﬁcer. The list of the private drug dispensing outlets was
further reﬁned to include only those facilities that were situated
within the catchment area (5 km radius or within 30 minutes
walking distance) of the selected health facilities. The sampling
frame from which outlets were drawn included four pharmacies
and 14 accredited drug dispensing outlets (ADDOs) in
Nyamagana district and two pharmacies and 10 ADDOs in Magu
district. One pharmacy and three ADDOs were randomly selected
from the list from each district. All adults (aged ≥18 years) visiting
selected private drug retail outlets from October 2013 to January
2014 were eligible to participate in the study. We made a conser-
vative estimate that each private drug retail outlet could receive
between 5 and 15 visitors a day of which 80% could be eligible
and 50% could be new clients.We assumed that across the eight
outlets we would be able to recruit 500 individuals per month. In
two months, an approximate sample of 1000 study participants
would be enough to understand the feasibility and acceptability
of the screening service.
Data collection
The person in charge at each private drug retail outlet was trained
on how to guide customers to take their own blood pressure using
a digital, semi-automated blood pressure monitor with advanced
oscillometric measurement (Model UA-767, A&D Company Ltd,
Tokyo, Japan.) The drug dispenser gathered information through
face to face interview using a questionnaire. No ﬁnancial incentive
was given to pharmacists or their customers at the onset of this
study out of concern that such an incentive would bias the data
collection and not support the sustainability of the intervention.
The questionnaire collected socio-demographic information,
exposure to previous hypertension/blood pressure information,
previous screening, diagnosis and/or treatment, telephone con-
tact details and patient satisfaction. Data were recorded manu-
ally and veriﬁed weekly by a ﬁeld supervisor. The person in charge
was not supposed to diagnose or give medication for study parti-
cipants found to have hypertension. After 5 minutes seated rest
consenting adults took their ﬁrst blood pressure reading, this was
repeated for the second reading. Only participants with high blood
pressure in both readings were classiﬁed as hypertension cases
and referred to the district hospital. The second reading was used
in the analysis. All participants should have been given pamphlets
containing information on hypertension prevention and risk fac-
tors as well as emphasizing the need for those with hypertension
to go for follow up.
At the outpatient department of the selected hospitals, a
dedicated nurse was trained to receive referred participants and
to complete the study speciﬁc referral slip. The nurse received
1000 Tanzanian Shillings (approximately US$0.5) for each cor-
rectly completed referral slip.
Four mystery clients (2 male, 2 female, all over 30 years)
were selected and trained on the study design and objectives,
how to enter the facility, how to ask for the service should it not
have been offered and how to rate the service. Their visits
occurred at random intervals throughout the study period on
different days. They entered the facilities for an unrelated ser-
vice and allowed the service provider time to offer the service;
should no service be offered they made a passing inquiry about
the blood pressure poster and waited to see if they were then
offered the service. After leaving the facility the research assist-
ant administered a short questionnaire. This component pro-
vided veriﬁcation on quality, ﬁdelity to the study protocol, and
how much time was utilized identifying, enrolling, consenting
and instructing participants into the study.
Telephone interviews were conducted with all participants
with hypertension and every ﬁfth form received from each facil-
ity with a normal reading. A semi-structured questionnaire was
used to investigate the service user perceptions of the service
and was conducted 2 weeks after the blood pressure reading to
allow for attendance at the health facility.
Follow up phone calls were used to verify referral slips. Bi-weekly
site visits were made by study personnel and real-time reports
were produced to ensure that pharmacists, drug dispensers, and
personnel in the referral sites were collecting the data properly.
Data management and statistical analysis
Data were double-entered, cleaned and validated using EpiData
version 3.1 (The EpiData Association, Odense, Denmark) and
exported to STATA 13 (Stata Corp, College Station, TX, USA).
Hypertension status was classiﬁed using the 7th report of the
Joint National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure Joint National Commit cri-
teria (JNC7 criteria).12 According to JNC7 criteria, hypertension
was deﬁned as blood pressure >140 mmHg and/or diastolic blood
pressure >90 mmHg and/or currently taking any antihypertensive
medication. Mystery client responses were grouped by district and
then by drug dispensing outlet to understand outlet speciﬁc situa-
tions. Open ended responses were post coded and described
qualitatively; quotations were used to highlight key ﬁndings.
Ethical issues
Written informed consent was obtained from each study partici-
pant before any data was collected or blood pressure measure-
ments were taken. An impartial witness was present for the
consent of illiterate participants, who then used a thumb print
to illustrate consent.
Results
A total of 971 study participants were approached to participate
in the study, of whom, 970 consented and were screened for
high blood pressure and recruited into the study. Only one per-
son declined to participate, for unknown reasons. A total 701
(72.2%) were recruited from six small drug retails outlets whilst
269 (21.8%) were from the large pharmacies. The majority of
the participants (529,54.6%) resided in the rural district of Magu
at the time of recruitment. Out of 970 study participants 494
(51.0%) were males and 664 (68.4%) were below 40 years of
age. The mean age for all study participants was 35 years (SD
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13.2). Characteristics of subjects with and without hypertension
are show in Table 1. The majority of participants reported to
have never heard of hypertension (639, 65.9%) or previously
measured their blood pressure (819, 84.4%).The majority of
those screened (861, 88.8%) recorded normal blood pressure
readings (see Table 2) and were not previously on any antihyper-
tensive drugs. The overall prevalence of hypertension amongst
the study participants was 109 (11.2%) of whom 85 (78.0%)
were newly diagnosed (see Figure 1).
Referral attendance and challenges of the screening
program
Only 18/85 (21%) of the newly diagnosed and only one of the
24 previously diagnosed cases attended referral within two
weeks of their referral. Of the 18, nine were aged 50 years and
above, 10 were male, 13 were married and 16 had a higher
education level.
Quality and acceptability of the service
A total of 340 study participants were selected to be contacted
by telephone after being screened: only 157 (46.2%) were suc-
cessfully reached and completed a questionnaire. No respond-
ent reported any problems with the service provided and all
were able to take their blood pressure readings. The majority
(133/157, 84.7%) reported they would recommend the service
to someone else. This ﬁnding did not vary by age, gender or
blood pressure reading.
Thirty two mystery client visits took place (see Table 3) across
eight facilities (four per facility). Service provision took between
3 and 75 minutes with a mean time of 20 minutes and over
half of the visits taking less than 18 minutes. The majority of
providers offered the service without the need for prompting
(25/32, 78%) and were able to fully explain the study (22/32;
69%). Findings from one facility showed that each mystery cli-
ent reported that the provider was unable to explain the testing
process and this was the same facility in which the provider
failed to explain the study completely. Mystery clients from
these facilities explained that instead of being told how to
measure their own blood pressure the provider simply took the
measurement themselves (in seven out of 32 facilities). In one
facility the blood pressure machine was being stored some-
where else and the provider had to leave the facility to locate
the machine (on the insistence of the mystery client).
All mystery clients reported that their questions were
answered fully when they asked them, however the majority
(21/30, 70%) reported to have not been given any leaﬂet.
The majority of mystery client visits recorded that the service
provider was friendly and helpful in explaining the steps (27/32,
84%). In addition to this four of the providers actively encour-
aged the mystery clients to invite others to come for the service.
Of the four mystery client visits that said the service providers
were friendly but too busy to help (4/32, 13%), three were from
the same facility in which they reported that the study and test-
ing process was not well explained.
Discussion
This pilot feasibility study has shown that screening for hyper-
tension at the private drug retail outlets was acceptable by
users of the service and possible to conduct by drug dispensers
and therefore could be feasible to offer on a larger scale. Only
Table1. Participants’ characteristics and factors associated with
hypertension, (n=970)
Variables Total % Hypertension %
All 970 109 11.2
Age category
18–29 426 43.9 13 11.9
30–39 238 24.5 23 21.1
40–49 147 15.2 26 23.9
>50 159 16.4 47 43.1
Sex
Female 467 48.1 59 54.1
Male 494 50.9 48 44.0
Missing 9 0.9 2 1.8
Marital status
Single 317 32.7 18 16.5
Married 596 61.4 83 76.1
Divorced 51 5.3 7 6.4
Missing 6 0.6 1 0.9
Occupation
Peasant 371 38.2 45 41.3
Employed 258 26.6 26 23.9
Business 334 34.4 36 33.0
Missing 7 0.7 2 1.8
Education
None 45 4.6 9 8.3
Primary 520 53.6 68 62.4
Secondary 296 30.5 24 22.0
Tertiary 101 10.4 7 6.4
Missing 8 0.8 1 0.9
District
Urban 441 45.5 42 38.5
BP Measured before
Yes 144 14.8 24 22.0
No 819 84.4 84 77.1
Missing 7 0.7 1 0.01
Heard of hypertension
Yes 322 33.2 40 36.7
No 639 65.9 68 62.4
Missing 9 0.9 1 0.9
Treated for hypertension
Yes 67 6.9 12 11.0
No 890 91.8 96 88.1
Missing 13 1.3 1 0.9
Drug outlet
Pharmacy 269 27.7 24 22.0
ADDO 701 72.3 85 78.0
ADDO: accredited drug dispensing outlets.
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one person refused the service (for unknown reasons), all others
were happy to screen themselves and would recommend the
service to others. The main diversion from the protocol involved
the service providers taking the measurement themselves
rather than instructing the clients to take their own; therefore
not always being offered as self-screening. Some medical per-
sonnel were concerned that measurement by the service pro-
vider would be seen, by some participants, as a diagnosis of
hypertension. Very low numbers of participants had ever heard
of hypertension or ever tested, highlighting a low level of aware-
ness of this rapidly growing health problem in this region and
suggestive of a large unmet need for screening services. The
screening identiﬁed a reasonable number of people with hyper-
tension (109/970, 11.2%) who were referred for further follow
up. However very few (19/109, 17.4%) attended a referral site
within two weeks of the referral.
Our study supports a number of other studies in sub-Saharan
Africa that highlight the worrying burden of hypertension in this
region of the world.2,3,6,7,13 Our ﬁndings support other studies
which show that very few individuals with hypertension were
previously diagnosed and fewer had their blood pressure under
control.7,14 Despite the high burden of disease, our study also
showed that, most people lacked knowledge and awareness
which could have negatively impacted on their timely access to
Table 2. Distribution of mean systolic and diastolic blood pressure by hypertension status and socio-demographic characteristics
Residence Sex Age group Number Systolic blood pressure Diastolic blood pressure
Mean (SD) 95% CI Mean (SD) 95% CI
Urban district
Male 18–29 77 123.5 (12.2) 121–126 78.5 (10.8) 76–81
30–39 56 126.1 (14.7) 122–130 81.6 (11.8) 78–85
40–49 27 132.0 (23.9) 123–141 82.6 (13.0) 78–88
>49 41 152.1 (28.9) 143–161 88.2 (13.8) 84–93
All 201 131.2 (21.8) 128–134 81.9 (12.5) 80–84
Female 18–29 111 118.8 (13.6) 116–121 80.5 (10.3) 79–82
30–39 68 121.2 (12.6) 118–124 83.6 (9.4) 81–86
40–49 28 130.8 (23.7) 122–140 88.0 (17.0) 81–95
>49 26 147.2 (35.1) 133–161 88.3 (15.6) 82–95
All 233 124.1 (20.3 121–127 83.2 (12.0) 82–85
Total 440 127.5 (21.3) 125–129 82.7 (12.3) 82–84
Rural district
Male 18–29 127 123.4 (18.0) 120–127 76.3 (10.9) 74–78
30–39 59 126.5 (17.1) 122–131 82.4 (12.6) 79–86
40–49 51 129.0 (19.6) 124–135 85.0 (14.2) 81–89
>49 55 137.2 (18.9) 132–142 85.0 (12.2) 82–88
All 292 127.6 (18.9) 125–130 80.7 (12.7) 79–82
Female 18–29 106 117.8 (17.8) 114–121 75.2 (12.8) 73–78
30–39 52 130.0 (24.2) 123–137 85.0 (16.8) 80–90
40–49 39 131.6 (17.8) 126–137 86.0 (14.3) 81–91
>49 36 143.2 (29.9) 133–153 90.1 (15.7) 85–95
All 233 126.7 (23.3) 124–130 81.5 (15.6) 79–84
Total 528 127.3 126–129 81.1 (14.1) 80–82
Combined
Male 18–29 204 123.4 (16.0) 121–126 77.1 (10.9) 76–79
30–39 115 126.5 (15.9) 123–129 82.0 (12.2) 80–84
40–49 78 130.1 (21.1) 125–135 84.0 (13.8) 81–87
>49 96 143.5 (24.6) 139–149 86.4 (13.0) 84–89
All 493 129.1 (20.2) 127–131 81.2 (12.6) 80–82
Female 18–29 217 118.3 (15.8) 116–120 77.9 (11.9) 76–79
30–39 120 125.0 (19.0) 122–128 84.2 (13.1) 82–87
40–49 67 131.2 (20.3) 126–136 86.8 (15.4) 83–91
>49 62 144.8 (32.0) 137–153 89.4 (15.6) 85–93
All 466 125.4 (21.9) 123–127 82.3 (14.0) 81–84
Total 968 127.4 (21.2) 126–129 81.8 (13.3) 81–83
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diagnosis and care. These ﬁndings suggest that public health
screening at private drug retail outlets, both ADDO and pharma-
cies, might be an acceptable and highly needed service to com-
pliment the routine healthcare delivery system.15
However our study documented low referral uptake. Less
than a quarter of study participants with high blood pressure
readings attended their referrals. Although there was a local
referral system set up between selected private drug retail out-
lets and nearby government-run hospital, some people could
have gone to other hospitals away from the study area, others
could have gone after the two week study follow up period
(such services are most typically offered at tertiary level facil-
ities). Uptake of hypertensive health services had been reported
to be low elsewhere in Tanzania.15 In a population-based study
in Dar es salaam, only 34% of those previously diagnosed with
hypertension were reported to have attended a formal health-
care provider within 12 months.15 Most studies elsewhere in
sub-Saharan Africa have documented low levels of awareness
which resulted in poor linkage to healthcare providers, and con-
trol, which can adversely affect treatment outcomes.2 More
research and intervention development is needed to design
better mechanisms for facilitating a timely referral to treatment
and management services.
Our study was a small pilot study and therefore has a num-
ber of limitations. Our study participants were recruited based
on their willingness to participate, therefore our responses could
be affected by volunteer bias, but only one person declined to
take part in the study; a telling result in itself in terms of accept-
ance of the service. The majority of study participants were
below 40 years of age possibly affecting the mean systolic blood
pressure results, that are less likely to rise in this age group.6
The intervention did not include any community based adver-
tisements of the service, which could help to attract different
demographic groups (i.e., older people). In our study we were
unable to calculate accurate prevalence estimates or assess
community level understanding and awareness of hypertension;
a community based survey would be needed to provide better
estimates but was out of the scope of this study. For the follow
up phone calls only 46% of the service users were reachable on
the phone numbers they gave during screening. This was a
much lower number than we expected. Our study suggests that
relying on a single mobile phone contact number per participant
Figure 1. Flow chart showing the study participants from recruitment, through screening and referral to attendance at referral.
D. Michael et al.
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was inadequate and additional information is needed in order
to maximize on mobile technology as part of any intervention.16
That being said, the sample reached included a representation
of ages and over one third had hypertension, which was
deemed sufﬁcient to ascertain how they rated the service in
terms of ease to conduct and whether they would recom-
mend it to a friend. More research is needed to understand
why some participants had their blood pressure measured by
the pharmacist attendant whilst others were left to measure
themselves. The study was only able to capture a small num-
ber of those attending referral and therefore we did not have
the power to investigate the factors associated with success-
ful referrals. A larger sample size and broader range of socio-
demographic and health system risk factors are needed to
investigate explanations for ineffective referrals among hyper-
tensive patients. Our study did not collect data to analyze the
time from diagnosis to attendance of the referral. Most cardio-
vascular complications of hypertension are caused by uncon-
trolled higher levels of diastolic and/or systolic blood pressure
for long periods of time. Greater focus should be on under-
standing how fast people with hypertension will navigate to
reach healthcare just after their diagnosis. Time taken from
initial diagnosis to blood pressure control may also be required
in future research.
Conclusions
The current pilot study suggests that it might be feasible and
acceptable to implement a hypertension screening intervention
program in private drug retail outlets in Tanzanian. Data from
projections and models have shown that the growing disease
burden due to chronic disease will cause most governments to
lose tens of billions of dollars from their national income.
Therefore, governments need to promote access to preventive
and treatment services.1 Low cost, scalable and equitable inter-
ventions are needed to improve access to prevention, identiﬁca-
tion and treatment services for chronic diseases including
hypertension.1
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